Alexey Ferapontov
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Alexey Ferapontov has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Søren Egedal Degn
Department of Biomedicine, Aarhus University, 8000 Aarhus, Denmark
2 shared publications - Alexandra Sophia Eklund
Navignostics AG, Horgen, Switzerland
1 shared publication - Cecilia Hagert
Department of Biomedicine Aarhus University Aarhus C Denmark
1 shared publication - Daniel Miotto Dupont
Aarhus University
1 shared publication Ewa Terczyńska‐Dyla
Department of Biomedicine Aarhus University Aarhus C Denmark
1 shared publication- Isabelle Baudrexel
Max Planck Institute of Biochemistry, Planegg, Germany
1 shared publication
Latest Publications
- Open Access
- 9 November 2023
- Published by Wiley in European Journal of Immunology
- Vol. 54 (1) , e2350422
Haplosufficiency of MHCII in autoreactive germinal center B cells
- 9 November 2023
- Published by Wiley in European Journal of Immunology
- Vol. 54 (1) , e2350422
Open AccessHaplosufficiency of MHCII in autoreactive germinal center B cells
- Open Access
- 22 February 2023
- Published by Springer Nature in Nature Communications
- Vol. 14 (1) , 1-20
Antigen footprint governs activation of the B cell receptor
Antigen binding by B cell receptors (BCR) on cognate B cells elicits a response that eventually leads to production of antibodies. However, it is unclear what the distribution of BCRs is on the naïve B cell and how antigen binding triggers the first step in BCR signaling. Using DNA-PAINT super-resolution microscopy, we find that most BCRs are present as monomers, dimers, or loosely associated clusters on resting B cells, with a nearest-neighbor inter-Fab distance of 20–30 nm. We leverage a Holliday junction nanoscaffold to engineer monodisperse model antigens with precision-controlled affinity and valency, and find that the antigen exerts agonistic effects on the BCR as a function of increasing affinity and avidity. Monovalent macromolecular antigens can activate the BCR at high concentrations, whereas micromolecular antigens cannot, demonstrating that antigen binding does not directly drive activation. Based on this, we propose a BCR activation model determined by the antigen footprint.
- 22 February 2023
- Published by Springer Nature in Nature Communications
- Vol. 14 (1) , 1-20
Open AccessAntigen footprint governs activation of the B cell receptor
Antigen binding by B cell receptors (BCR) on cognate B cells elicits a response that eventually leads to production of antibodies. However, it is unclear what the distribution of BCRs is on the naïve B cell and how antigen binding triggers the first step in BCR signaling. Using DNA-PAINT super-resolution microscopy, we find that most BCRs are present as monomers, dimers, or loosely associated clusters on resting B cells, with a nearest-neighbor inter-Fab distance of 20–30 nm. We leverage a Holliday junction nanoscaffold to engineer monodisperse model antigens with precision-controlled affinity and valency, and find that the antigen exerts agonistic effects on the BCR as a function of increasing affinity and avidity. Monovalent macromolecular antigens can activate the BCR at high concentrations, whereas micromolecular antigens cannot, demonstrating that antigen binding does not directly drive activation. Based on this, we propose a BCR activation model determined by the antigen footprint.